CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Sonoclot Analyzerdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02588976
NCT02588976N/ACompleted
CompareCT.gov

Evaluation of a New Sonoclot Device for Heparin Management in Cardiac Surgery

Triemli Hospital·interventional·Posted Oct 28, 2015·Updated May 4, 2018

In Brief

A clinical study evaluating Sonoclot Analyzer for Diagnostic Techniques and Procedures and Cardiac Surgical Procedure. Completed, enrolled 30 participants.

Detailed Summary

The SONOCLOT Analyzer (S1; Sienco, Inc. Boulder, CO USA, Model DP-2951) is used to perform kaolin-based activated clotting time as routine monitor of heparin therapy in patients undergoing cardiac operations. In addition, the device allows the assessment of the patient's coagulation status by a glass-bead activated test. Recently, a new SONOCLOT analyzer (S2) has been developed. As part of the routine management using S1, tests are also performed on S2. Results are entered into the cardiac surgery data base of all cardiac surgery patients and analyzed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiagnostic Techniques and Procedures, Cardiac Surgical Procedure
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 28, 2015
Enrollment StartJul 1, 2009
Primary CompletionJan 1, 2010
Study CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.7 years ago

Interventions

Sonoclot Analyzerdevice

Blood coagulation test during cardiac surgery: Measurement of activated clotting time during cardiac surgery by Sonoclot Analyzer